On October 28, genetically modified cells were injected into a patient at the West China Hospital in Chengdu with aggressive lung cancer, according to the scientific journal Nature The team of scientists, led by Lu You of Sichuan University, extracted immune cells from the patients and edited them using CRISPR-Cas9.